Loading...
•
Sep 30, 2023
DexCom Q3 2023 Earnings Report
Reported solid financial results and advanced global access to Dexcom CGM.
Key Takeaways
Dexcom's Q3 2023 revenue grew by 27% year-over-year to $975.0 million. The company raised its full-year revenue and margin guidance and announced a $500 million share repurchase program.
Revenue grew 27% versus the same quarter of the prior year to $975.0 million.
U.S. revenue growth of 24% and international revenue growth of 33%.
GAAP operating income of $205.5 million or 21.1% of revenue.
Secured reimbursement for Dexcom ONE in France.
DexCom
DexCom
DexCom Revenue by Segment
DexCom Revenue by Geographic Location
Revenue by Segment
Sensor and other Revenue
CapyFin.comHardware Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The company is increasing fiscal year 2023 guidance for Revenue, Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin.
Positive Outlook
- Revenue of approximately $3.575 - 3.600 billion (23-24% growth)
- Non-GAAP Gross Profit Margin of approximately 64%
- Non-GAAP Operating Margin of approximately 19%
- Adjusted EBITDA Margin of approximately 28%
Revenue & Expenses
Visualization of income flow from segment revenue to net income